Company / Interest Expense
RHYTHM PHARMACEUTICALS, INC. Interest Expense History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$13.9M
FY2023
5-year range
$5.2M / $13.9M
FY2022-FY2023
Trend
+167.1%
vs FY2022
Sector context
#23 of 44
Health Care
What the data says
At $14M, RHYTHM PHARMACEUTICALS, INC.'s interest expense ranks #22 of 44 in the Health Care sector.
Based on SEC 10-K filings.
$14M in FY2023.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#22 of 44 in Health CareTop 48% of 44This company $13.9M Sector average $291.0M
▼
-95.2% below sector average
Key checks
Key Insights
- In FY2023, interest expense increased 167.1% year-over-year.
- Ranks #23 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $13.9M | +167.1% |
| FY2022 | $5.2M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026